Trustees of Columbia University in the City of New York’s RAPT Therapeutics RAPT Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,172	Closed	-$237K	–	5
2025 Q3	$237K	Buy	+9,172	New	+$120K	0.04%	5
2025 Q2	–	Sell	-9,173	Closed	-$89.5K	–	11
2025 Q1	$89.5K	Hold	9,173	–	–	0.01%	8
2024 Q4	$116K	Buy	+9,173	New	+$117K	0.02%	11
2023 Q4	$1.82M	Hold	9,173	–	–	3.85%	2
2023 Q3	$1.22M	Hold	9,173	–	–	2.24%	4
2023 Q2	$1.37M	Sell	9,173 -900	-9%	-$140K	2.01%	7
2023 Q1	$1.48M	Buy	10,073 +900	+10%	+$182K	2.65%	7
2022 Q4	$1.45M	Buy	+9,173	New	+$1.47M	2.99%	5
2021 Q3	$2.28M	Sell	9,173 -603	-6%	-$159K	3.49%	6
2021 Q2	$2.49M	Buy	9,776 +603	+7%	+$113K	3.67%	6
2021 Q1	$1.63M	Hold	9,173	–	–	1.97%	6
2020 Q4	$1.45M	Buy	+9,173	New	+$1.99M	1.94%	5

Other funds holding RAPT

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Trustees of Columbia University in the City of New York's RAPT Position: Q4 2025 in Review

Trustees of Columbia University in the City of New York sold out of RAPT Therapeutics (RAPT) in Q4 2025, closing a stake of 9,172 shares — an estimated $237K sold.

Trustees of Columbia University in the City of New York first reported a position in RAPT in Q4 2020 and held it in 12 quarters. The position peaked at $2.49M in Q2 2021. 105 funds tracked by Wall St. Rank hold RAPT as of Q4 2025.

Trustees of Columbia University in the City of New York reported no remaining RAPT Therapeutics position as of Q4 2025 after selling out during the quarter.
Trustees of Columbia University in the City of New York sold 9,172 RAPT Therapeutics shares in Q4 2025, an estimated $237K.
Trustees of Columbia University in the City of New York first reported a position in RAPT Therapeutics in Q4 2020 and held it in 12 quarters.
Trustees of Columbia University in the City of New York's RAPT Therapeutics position peaked at $2.49M in Q2 2021.
105 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2025.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q4 2025, filed 13 Feb 2026.